Cite
Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison
MLA
Marco Scaglione, et al. “Cardiac Amyloidosis and Hypertrophic Cardiomyopathy: A Dangerous Liaison.” Global Cardiology Science & Practice, vol. 2013, no. 4, Dec. 2013, pp. 405–08. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....81e79fc5e70d344811666681f6cabdfd&authtype=sso&custid=ns315887.
APA
Marco Scaglione, Salvatore Miceli, Stefano Leuzzi, Elisa Ebrille, Paolo Di Donna, & Fiorenzo Gaita. (2013). Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison. Global Cardiology Science & Practice, 2013(4), 405–408.
Chicago
Marco Scaglione, Salvatore Miceli, Stefano Leuzzi, Elisa Ebrille, Paolo Di Donna, and Fiorenzo Gaita. 2013. “Cardiac Amyloidosis and Hypertrophic Cardiomyopathy: A Dangerous Liaison.” Global Cardiology Science & Practice 2013 (4): 405–8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....81e79fc5e70d344811666681f6cabdfd&authtype=sso&custid=ns315887.